A number of companies have clarified that "there is no fenugreek"! Beware of second-degree speculation in risk concept stocks_Sina Finance_Sina.com Post date May 17, 2022 — 15:02 Post Lock Read More A number of companies have clarified that "there is no fenugreek"! Beware of the risk of second-degree speculation CFi.CN Zhongcai Network Post date May 17, 2022 — 14:57 Post Lock Read More A number of companies have clarified that "there is no fenugreek"! Beware of the risk of second-degree speculation Post date May 17, 2022 — 14:10 Post Lock Read More A number of companies have clarified that "there is no fenugreek"! Beware of the risk of second-degree speculation Post date May 17, 2022 — 12:42 Post Lock Read More Jiuzhitang: Stem cell clinical trial project is conducting dose escalation research Teller Report Post date May 16, 2022 — 21:51 Post Lock Read More Jiuzhitang: Stem cell clinical trial project is conducting dose escalation research_Securities Times Post date May 16, 2022 — 21:50 Post Lock Read More Jiuzhitang: Stem cell clinical trial project is conducting dose escalation research Finance and Economics Post date May 16, 2022 — 21:50 Post Lock Read More Zhendong Pharmaceutical Receives Annual Report Inquiry Letters for Three Consecutive Years, Sales of Many Major Categories Decline Post date May 13, 2022 — 11:03 Post Lock Read More Zhendong Pharmaceutical has received a letter of inquiry about the annual report for three consecutive years. The sale of its subsidiary has taken out Fangyuan Capital. Zhendong Pharmaceutical, Fangyuan Capital, Shenzhen Stock Exchange_Sina Technology_Sina.com Post date May 13, 2022 — 08:55 Post Lock Read More Zhendong Pharmaceutical Receives Annual Report Inquiry Letters for Three Consecutive Years Post date May 13, 2022 — 08:50 Post Lock Read More Yifeng Pharmacy was surveyed by 61 institutions: the company adopts the full retrospective method, the annual report has retrospectively adjusted the data in 2020, and the impact of the new standards on 2021 has been eliminated (with survey questions and answers) Post date May 7, 2022 — 12:08 Post Lock Read More The late trading rose sharply, and the pharmaceutical sector once again became the "sweet pastry" of institutions under the high prosperity of the industry Post date May 6, 2022 — 18:35 Post Lock Read More Yifeng Pharmacy's 2021 revenue and net profit growth slowed down, the acquisition of Jiuzhitang's pharmacy was questioned as a "distribution-style acquisition" Financial Channel Rongyi Information Network Post date May 6, 2022 — 16:21 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits grow steadily, and store expansion accelerates – yqqlm Post date May 3, 2022 — 12:20 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits are growing steadily, and store expansion is accelerating. Post date May 3, 2022 — 12:19 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Is Dong E E Jiao a donkey or a horse or a mystery? Post date April 30, 2022 — 18:50 Post Lock Read More Dong-E-Ejiao, to make amends after the sheep is gone Post date April 29, 2022 — 19:23 Post Lock Read More Dong'e Ejiao "repairs after the sheep" Post date April 29, 2022 — 19:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
A number of companies have clarified that "there is no fenugreek"! Beware of the risk of second-degree speculation CFi.CN Zhongcai Network Post date May 17, 2022 — 14:57 Post Lock Read More A number of companies have clarified that "there is no fenugreek"! Beware of the risk of second-degree speculation Post date May 17, 2022 — 14:10 Post Lock Read More A number of companies have clarified that "there is no fenugreek"! Beware of the risk of second-degree speculation Post date May 17, 2022 — 12:42 Post Lock Read More Jiuzhitang: Stem cell clinical trial project is conducting dose escalation research Teller Report Post date May 16, 2022 — 21:51 Post Lock Read More Jiuzhitang: Stem cell clinical trial project is conducting dose escalation research_Securities Times Post date May 16, 2022 — 21:50 Post Lock Read More Jiuzhitang: Stem cell clinical trial project is conducting dose escalation research Finance and Economics Post date May 16, 2022 — 21:50 Post Lock Read More Zhendong Pharmaceutical Receives Annual Report Inquiry Letters for Three Consecutive Years, Sales of Many Major Categories Decline Post date May 13, 2022 — 11:03 Post Lock Read More Zhendong Pharmaceutical has received a letter of inquiry about the annual report for three consecutive years. The sale of its subsidiary has taken out Fangyuan Capital. Zhendong Pharmaceutical, Fangyuan Capital, Shenzhen Stock Exchange_Sina Technology_Sina.com Post date May 13, 2022 — 08:55 Post Lock Read More Zhendong Pharmaceutical Receives Annual Report Inquiry Letters for Three Consecutive Years Post date May 13, 2022 — 08:50 Post Lock Read More Yifeng Pharmacy was surveyed by 61 institutions: the company adopts the full retrospective method, the annual report has retrospectively adjusted the data in 2020, and the impact of the new standards on 2021 has been eliminated (with survey questions and answers) Post date May 7, 2022 — 12:08 Post Lock Read More The late trading rose sharply, and the pharmaceutical sector once again became the "sweet pastry" of institutions under the high prosperity of the industry Post date May 6, 2022 — 18:35 Post Lock Read More Yifeng Pharmacy's 2021 revenue and net profit growth slowed down, the acquisition of Jiuzhitang's pharmacy was questioned as a "distribution-style acquisition" Financial Channel Rongyi Information Network Post date May 6, 2022 — 16:21 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits grow steadily, and store expansion accelerates – yqqlm Post date May 3, 2022 — 12:20 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits are growing steadily, and store expansion is accelerating. Post date May 3, 2022 — 12:19 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Is Dong E E Jiao a donkey or a horse or a mystery? Post date April 30, 2022 — 18:50 Post Lock Read More Dong-E-Ejiao, to make amends after the sheep is gone Post date April 29, 2022 — 19:23 Post Lock Read More Dong'e Ejiao "repairs after the sheep" Post date April 29, 2022 — 19:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
A number of companies have clarified that "there is no fenugreek"! Beware of the risk of second-degree speculation Post date May 17, 2022 — 14:10 Post Lock Read More A number of companies have clarified that "there is no fenugreek"! Beware of the risk of second-degree speculation Post date May 17, 2022 — 12:42 Post Lock Read More Jiuzhitang: Stem cell clinical trial project is conducting dose escalation research Teller Report Post date May 16, 2022 — 21:51 Post Lock Read More Jiuzhitang: Stem cell clinical trial project is conducting dose escalation research_Securities Times Post date May 16, 2022 — 21:50 Post Lock Read More Jiuzhitang: Stem cell clinical trial project is conducting dose escalation research Finance and Economics Post date May 16, 2022 — 21:50 Post Lock Read More Zhendong Pharmaceutical Receives Annual Report Inquiry Letters for Three Consecutive Years, Sales of Many Major Categories Decline Post date May 13, 2022 — 11:03 Post Lock Read More Zhendong Pharmaceutical has received a letter of inquiry about the annual report for three consecutive years. The sale of its subsidiary has taken out Fangyuan Capital. Zhendong Pharmaceutical, Fangyuan Capital, Shenzhen Stock Exchange_Sina Technology_Sina.com Post date May 13, 2022 — 08:55 Post Lock Read More Zhendong Pharmaceutical Receives Annual Report Inquiry Letters for Three Consecutive Years Post date May 13, 2022 — 08:50 Post Lock Read More Yifeng Pharmacy was surveyed by 61 institutions: the company adopts the full retrospective method, the annual report has retrospectively adjusted the data in 2020, and the impact of the new standards on 2021 has been eliminated (with survey questions and answers) Post date May 7, 2022 — 12:08 Post Lock Read More The late trading rose sharply, and the pharmaceutical sector once again became the "sweet pastry" of institutions under the high prosperity of the industry Post date May 6, 2022 — 18:35 Post Lock Read More Yifeng Pharmacy's 2021 revenue and net profit growth slowed down, the acquisition of Jiuzhitang's pharmacy was questioned as a "distribution-style acquisition" Financial Channel Rongyi Information Network Post date May 6, 2022 — 16:21 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits grow steadily, and store expansion accelerates – yqqlm Post date May 3, 2022 — 12:20 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits are growing steadily, and store expansion is accelerating. Post date May 3, 2022 — 12:19 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Is Dong E E Jiao a donkey or a horse or a mystery? Post date April 30, 2022 — 18:50 Post Lock Read More Dong-E-Ejiao, to make amends after the sheep is gone Post date April 29, 2022 — 19:23 Post Lock Read More Dong'e Ejiao "repairs after the sheep" Post date April 29, 2022 — 19:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
A number of companies have clarified that "there is no fenugreek"! Beware of the risk of second-degree speculation Post date May 17, 2022 — 12:42 Post Lock Read More Jiuzhitang: Stem cell clinical trial project is conducting dose escalation research Teller Report Post date May 16, 2022 — 21:51 Post Lock Read More Jiuzhitang: Stem cell clinical trial project is conducting dose escalation research_Securities Times Post date May 16, 2022 — 21:50 Post Lock Read More Jiuzhitang: Stem cell clinical trial project is conducting dose escalation research Finance and Economics Post date May 16, 2022 — 21:50 Post Lock Read More Zhendong Pharmaceutical Receives Annual Report Inquiry Letters for Three Consecutive Years, Sales of Many Major Categories Decline Post date May 13, 2022 — 11:03 Post Lock Read More Zhendong Pharmaceutical has received a letter of inquiry about the annual report for three consecutive years. The sale of its subsidiary has taken out Fangyuan Capital. Zhendong Pharmaceutical, Fangyuan Capital, Shenzhen Stock Exchange_Sina Technology_Sina.com Post date May 13, 2022 — 08:55 Post Lock Read More Zhendong Pharmaceutical Receives Annual Report Inquiry Letters for Three Consecutive Years Post date May 13, 2022 — 08:50 Post Lock Read More Yifeng Pharmacy was surveyed by 61 institutions: the company adopts the full retrospective method, the annual report has retrospectively adjusted the data in 2020, and the impact of the new standards on 2021 has been eliminated (with survey questions and answers) Post date May 7, 2022 — 12:08 Post Lock Read More The late trading rose sharply, and the pharmaceutical sector once again became the "sweet pastry" of institutions under the high prosperity of the industry Post date May 6, 2022 — 18:35 Post Lock Read More Yifeng Pharmacy's 2021 revenue and net profit growth slowed down, the acquisition of Jiuzhitang's pharmacy was questioned as a "distribution-style acquisition" Financial Channel Rongyi Information Network Post date May 6, 2022 — 16:21 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits grow steadily, and store expansion accelerates – yqqlm Post date May 3, 2022 — 12:20 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits are growing steadily, and store expansion is accelerating. Post date May 3, 2022 — 12:19 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Is Dong E E Jiao a donkey or a horse or a mystery? Post date April 30, 2022 — 18:50 Post Lock Read More Dong-E-Ejiao, to make amends after the sheep is gone Post date April 29, 2022 — 19:23 Post Lock Read More Dong'e Ejiao "repairs after the sheep" Post date April 29, 2022 — 19:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Jiuzhitang: Stem cell clinical trial project is conducting dose escalation research Teller Report Post date May 16, 2022 — 21:51 Post Lock Read More Jiuzhitang: Stem cell clinical trial project is conducting dose escalation research_Securities Times Post date May 16, 2022 — 21:50 Post Lock Read More Jiuzhitang: Stem cell clinical trial project is conducting dose escalation research Finance and Economics Post date May 16, 2022 — 21:50 Post Lock Read More Zhendong Pharmaceutical Receives Annual Report Inquiry Letters for Three Consecutive Years, Sales of Many Major Categories Decline Post date May 13, 2022 — 11:03 Post Lock Read More Zhendong Pharmaceutical has received a letter of inquiry about the annual report for three consecutive years. The sale of its subsidiary has taken out Fangyuan Capital. Zhendong Pharmaceutical, Fangyuan Capital, Shenzhen Stock Exchange_Sina Technology_Sina.com Post date May 13, 2022 — 08:55 Post Lock Read More Zhendong Pharmaceutical Receives Annual Report Inquiry Letters for Three Consecutive Years Post date May 13, 2022 — 08:50 Post Lock Read More Yifeng Pharmacy was surveyed by 61 institutions: the company adopts the full retrospective method, the annual report has retrospectively adjusted the data in 2020, and the impact of the new standards on 2021 has been eliminated (with survey questions and answers) Post date May 7, 2022 — 12:08 Post Lock Read More The late trading rose sharply, and the pharmaceutical sector once again became the "sweet pastry" of institutions under the high prosperity of the industry Post date May 6, 2022 — 18:35 Post Lock Read More Yifeng Pharmacy's 2021 revenue and net profit growth slowed down, the acquisition of Jiuzhitang's pharmacy was questioned as a "distribution-style acquisition" Financial Channel Rongyi Information Network Post date May 6, 2022 — 16:21 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits grow steadily, and store expansion accelerates – yqqlm Post date May 3, 2022 — 12:20 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits are growing steadily, and store expansion is accelerating. Post date May 3, 2022 — 12:19 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Is Dong E E Jiao a donkey or a horse or a mystery? Post date April 30, 2022 — 18:50 Post Lock Read More Dong-E-Ejiao, to make amends after the sheep is gone Post date April 29, 2022 — 19:23 Post Lock Read More Dong'e Ejiao "repairs after the sheep" Post date April 29, 2022 — 19:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Jiuzhitang: Stem cell clinical trial project is conducting dose escalation research_Securities Times Post date May 16, 2022 — 21:50 Post Lock Read More Jiuzhitang: Stem cell clinical trial project is conducting dose escalation research Finance and Economics Post date May 16, 2022 — 21:50 Post Lock Read More Zhendong Pharmaceutical Receives Annual Report Inquiry Letters for Three Consecutive Years, Sales of Many Major Categories Decline Post date May 13, 2022 — 11:03 Post Lock Read More Zhendong Pharmaceutical has received a letter of inquiry about the annual report for three consecutive years. The sale of its subsidiary has taken out Fangyuan Capital. Zhendong Pharmaceutical, Fangyuan Capital, Shenzhen Stock Exchange_Sina Technology_Sina.com Post date May 13, 2022 — 08:55 Post Lock Read More Zhendong Pharmaceutical Receives Annual Report Inquiry Letters for Three Consecutive Years Post date May 13, 2022 — 08:50 Post Lock Read More Yifeng Pharmacy was surveyed by 61 institutions: the company adopts the full retrospective method, the annual report has retrospectively adjusted the data in 2020, and the impact of the new standards on 2021 has been eliminated (with survey questions and answers) Post date May 7, 2022 — 12:08 Post Lock Read More The late trading rose sharply, and the pharmaceutical sector once again became the "sweet pastry" of institutions under the high prosperity of the industry Post date May 6, 2022 — 18:35 Post Lock Read More Yifeng Pharmacy's 2021 revenue and net profit growth slowed down, the acquisition of Jiuzhitang's pharmacy was questioned as a "distribution-style acquisition" Financial Channel Rongyi Information Network Post date May 6, 2022 — 16:21 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits grow steadily, and store expansion accelerates – yqqlm Post date May 3, 2022 — 12:20 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits are growing steadily, and store expansion is accelerating. Post date May 3, 2022 — 12:19 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Is Dong E E Jiao a donkey or a horse or a mystery? Post date April 30, 2022 — 18:50 Post Lock Read More Dong-E-Ejiao, to make amends after the sheep is gone Post date April 29, 2022 — 19:23 Post Lock Read More Dong'e Ejiao "repairs after the sheep" Post date April 29, 2022 — 19:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Jiuzhitang: Stem cell clinical trial project is conducting dose escalation research Finance and Economics Post date May 16, 2022 — 21:50 Post Lock Read More Zhendong Pharmaceutical Receives Annual Report Inquiry Letters for Three Consecutive Years, Sales of Many Major Categories Decline Post date May 13, 2022 — 11:03 Post Lock Read More Zhendong Pharmaceutical has received a letter of inquiry about the annual report for three consecutive years. The sale of its subsidiary has taken out Fangyuan Capital. Zhendong Pharmaceutical, Fangyuan Capital, Shenzhen Stock Exchange_Sina Technology_Sina.com Post date May 13, 2022 — 08:55 Post Lock Read More Zhendong Pharmaceutical Receives Annual Report Inquiry Letters for Three Consecutive Years Post date May 13, 2022 — 08:50 Post Lock Read More Yifeng Pharmacy was surveyed by 61 institutions: the company adopts the full retrospective method, the annual report has retrospectively adjusted the data in 2020, and the impact of the new standards on 2021 has been eliminated (with survey questions and answers) Post date May 7, 2022 — 12:08 Post Lock Read More The late trading rose sharply, and the pharmaceutical sector once again became the "sweet pastry" of institutions under the high prosperity of the industry Post date May 6, 2022 — 18:35 Post Lock Read More Yifeng Pharmacy's 2021 revenue and net profit growth slowed down, the acquisition of Jiuzhitang's pharmacy was questioned as a "distribution-style acquisition" Financial Channel Rongyi Information Network Post date May 6, 2022 — 16:21 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits grow steadily, and store expansion accelerates – yqqlm Post date May 3, 2022 — 12:20 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits are growing steadily, and store expansion is accelerating. Post date May 3, 2022 — 12:19 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Is Dong E E Jiao a donkey or a horse or a mystery? Post date April 30, 2022 — 18:50 Post Lock Read More Dong-E-Ejiao, to make amends after the sheep is gone Post date April 29, 2022 — 19:23 Post Lock Read More Dong'e Ejiao "repairs after the sheep" Post date April 29, 2022 — 19:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zhendong Pharmaceutical Receives Annual Report Inquiry Letters for Three Consecutive Years, Sales of Many Major Categories Decline Post date May 13, 2022 — 11:03 Post Lock Read More Zhendong Pharmaceutical has received a letter of inquiry about the annual report for three consecutive years. The sale of its subsidiary has taken out Fangyuan Capital. Zhendong Pharmaceutical, Fangyuan Capital, Shenzhen Stock Exchange_Sina Technology_Sina.com Post date May 13, 2022 — 08:55 Post Lock Read More Zhendong Pharmaceutical Receives Annual Report Inquiry Letters for Three Consecutive Years Post date May 13, 2022 — 08:50 Post Lock Read More Yifeng Pharmacy was surveyed by 61 institutions: the company adopts the full retrospective method, the annual report has retrospectively adjusted the data in 2020, and the impact of the new standards on 2021 has been eliminated (with survey questions and answers) Post date May 7, 2022 — 12:08 Post Lock Read More The late trading rose sharply, and the pharmaceutical sector once again became the "sweet pastry" of institutions under the high prosperity of the industry Post date May 6, 2022 — 18:35 Post Lock Read More Yifeng Pharmacy's 2021 revenue and net profit growth slowed down, the acquisition of Jiuzhitang's pharmacy was questioned as a "distribution-style acquisition" Financial Channel Rongyi Information Network Post date May 6, 2022 — 16:21 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits grow steadily, and store expansion accelerates – yqqlm Post date May 3, 2022 — 12:20 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits are growing steadily, and store expansion is accelerating. Post date May 3, 2022 — 12:19 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Is Dong E E Jiao a donkey or a horse or a mystery? Post date April 30, 2022 — 18:50 Post Lock Read More Dong-E-Ejiao, to make amends after the sheep is gone Post date April 29, 2022 — 19:23 Post Lock Read More Dong'e Ejiao "repairs after the sheep" Post date April 29, 2022 — 19:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zhendong Pharmaceutical has received a letter of inquiry about the annual report for three consecutive years. The sale of its subsidiary has taken out Fangyuan Capital. Zhendong Pharmaceutical, Fangyuan Capital, Shenzhen Stock Exchange_Sina Technology_Sina.com Post date May 13, 2022 — 08:55 Post Lock Read More Zhendong Pharmaceutical Receives Annual Report Inquiry Letters for Three Consecutive Years Post date May 13, 2022 — 08:50 Post Lock Read More Yifeng Pharmacy was surveyed by 61 institutions: the company adopts the full retrospective method, the annual report has retrospectively adjusted the data in 2020, and the impact of the new standards on 2021 has been eliminated (with survey questions and answers) Post date May 7, 2022 — 12:08 Post Lock Read More The late trading rose sharply, and the pharmaceutical sector once again became the "sweet pastry" of institutions under the high prosperity of the industry Post date May 6, 2022 — 18:35 Post Lock Read More Yifeng Pharmacy's 2021 revenue and net profit growth slowed down, the acquisition of Jiuzhitang's pharmacy was questioned as a "distribution-style acquisition" Financial Channel Rongyi Information Network Post date May 6, 2022 — 16:21 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits grow steadily, and store expansion accelerates – yqqlm Post date May 3, 2022 — 12:20 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits are growing steadily, and store expansion is accelerating. Post date May 3, 2022 — 12:19 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Is Dong E E Jiao a donkey or a horse or a mystery? Post date April 30, 2022 — 18:50 Post Lock Read More Dong-E-Ejiao, to make amends after the sheep is gone Post date April 29, 2022 — 19:23 Post Lock Read More Dong'e Ejiao "repairs after the sheep" Post date April 29, 2022 — 19:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zhendong Pharmaceutical Receives Annual Report Inquiry Letters for Three Consecutive Years Post date May 13, 2022 — 08:50 Post Lock Read More Yifeng Pharmacy was surveyed by 61 institutions: the company adopts the full retrospective method, the annual report has retrospectively adjusted the data in 2020, and the impact of the new standards on 2021 has been eliminated (with survey questions and answers) Post date May 7, 2022 — 12:08 Post Lock Read More The late trading rose sharply, and the pharmaceutical sector once again became the "sweet pastry" of institutions under the high prosperity of the industry Post date May 6, 2022 — 18:35 Post Lock Read More Yifeng Pharmacy's 2021 revenue and net profit growth slowed down, the acquisition of Jiuzhitang's pharmacy was questioned as a "distribution-style acquisition" Financial Channel Rongyi Information Network Post date May 6, 2022 — 16:21 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits grow steadily, and store expansion accelerates – yqqlm Post date May 3, 2022 — 12:20 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits are growing steadily, and store expansion is accelerating. Post date May 3, 2022 — 12:19 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Is Dong E E Jiao a donkey or a horse or a mystery? Post date April 30, 2022 — 18:50 Post Lock Read More Dong-E-Ejiao, to make amends after the sheep is gone Post date April 29, 2022 — 19:23 Post Lock Read More Dong'e Ejiao "repairs after the sheep" Post date April 29, 2022 — 19:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Yifeng Pharmacy was surveyed by 61 institutions: the company adopts the full retrospective method, the annual report has retrospectively adjusted the data in 2020, and the impact of the new standards on 2021 has been eliminated (with survey questions and answers) Post date May 7, 2022 — 12:08 Post Lock Read More The late trading rose sharply, and the pharmaceutical sector once again became the "sweet pastry" of institutions under the high prosperity of the industry Post date May 6, 2022 — 18:35 Post Lock Read More Yifeng Pharmacy's 2021 revenue and net profit growth slowed down, the acquisition of Jiuzhitang's pharmacy was questioned as a "distribution-style acquisition" Financial Channel Rongyi Information Network Post date May 6, 2022 — 16:21 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits grow steadily, and store expansion accelerates – yqqlm Post date May 3, 2022 — 12:20 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits are growing steadily, and store expansion is accelerating. Post date May 3, 2022 — 12:19 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Is Dong E E Jiao a donkey or a horse or a mystery? Post date April 30, 2022 — 18:50 Post Lock Read More Dong-E-Ejiao, to make amends after the sheep is gone Post date April 29, 2022 — 19:23 Post Lock Read More Dong'e Ejiao "repairs after the sheep" Post date April 29, 2022 — 19:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The late trading rose sharply, and the pharmaceutical sector once again became the "sweet pastry" of institutions under the high prosperity of the industry Post date May 6, 2022 — 18:35 Post Lock Read More Yifeng Pharmacy's 2021 revenue and net profit growth slowed down, the acquisition of Jiuzhitang's pharmacy was questioned as a "distribution-style acquisition" Financial Channel Rongyi Information Network Post date May 6, 2022 — 16:21 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits grow steadily, and store expansion accelerates – yqqlm Post date May 3, 2022 — 12:20 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits are growing steadily, and store expansion is accelerating. Post date May 3, 2022 — 12:19 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Is Dong E E Jiao a donkey or a horse or a mystery? Post date April 30, 2022 — 18:50 Post Lock Read More Dong-E-Ejiao, to make amends after the sheep is gone Post date April 29, 2022 — 19:23 Post Lock Read More Dong'e Ejiao "repairs after the sheep" Post date April 29, 2022 — 19:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Yifeng Pharmacy's 2021 revenue and net profit growth slowed down, the acquisition of Jiuzhitang's pharmacy was questioned as a "distribution-style acquisition" Financial Channel Rongyi Information Network Post date May 6, 2022 — 16:21 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits grow steadily, and store expansion accelerates – yqqlm Post date May 3, 2022 — 12:20 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits are growing steadily, and store expansion is accelerating. Post date May 3, 2022 — 12:19 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Is Dong E E Jiao a donkey or a horse or a mystery? Post date April 30, 2022 — 18:50 Post Lock Read More Dong-E-Ejiao, to make amends after the sheep is gone Post date April 29, 2022 — 19:23 Post Lock Read More Dong'e Ejiao "repairs after the sheep" Post date April 29, 2022 — 19:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits grow steadily, and store expansion accelerates – yqqlm Post date May 3, 2022 — 12:20 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits are growing steadily, and store expansion is accelerating. Post date May 3, 2022 — 12:19 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Is Dong E E Jiao a donkey or a horse or a mystery? Post date April 30, 2022 — 18:50 Post Lock Read More Dong-E-Ejiao, to make amends after the sheep is gone Post date April 29, 2022 — 19:23 Post Lock Read More Dong'e Ejiao "repairs after the sheep" Post date April 29, 2022 — 19:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits grow steadily, and store expansion accelerates – yqqlm Post date May 3, 2022 — 12:20 Post Lock Read More Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits are growing steadily, and store expansion is accelerating. Post date May 3, 2022 — 12:19 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Is Dong E E Jiao a donkey or a horse or a mystery? Post date April 30, 2022 — 18:50 Post Lock Read More Dong-E-Ejiao, to make amends after the sheep is gone Post date April 29, 2022 — 19:23 Post Lock Read More Dong'e Ejiao "repairs after the sheep" Post date April 29, 2022 — 19:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits are growing steadily, and store expansion is accelerating. Post date May 3, 2022 — 12:19 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Is Dong E E Jiao a donkey or a horse or a mystery? Post date April 30, 2022 — 18:50 Post Lock Read More Dong-E-Ejiao, to make amends after the sheep is gone Post date April 29, 2022 — 19:23 Post Lock Read More Dong'e Ejiao "repairs after the sheep" Post date April 29, 2022 — 19:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Is Dong E E Jiao a donkey or a horse or a mystery? Post date April 30, 2022 — 18:50 Post Lock Read More Dong-E-Ejiao, to make amends after the sheep is gone Post date April 29, 2022 — 19:23 Post Lock Read More Dong'e Ejiao "repairs after the sheep" Post date April 29, 2022 — 19:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Is Dong E E Jiao a donkey or a horse or a mystery? Post date April 30, 2022 — 18:50 Post Lock Read More Dong-E-Ejiao, to make amends after the sheep is gone Post date April 29, 2022 — 19:23 Post Lock Read More Dong'e Ejiao "repairs after the sheep" Post date April 29, 2022 — 19:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Dong-E-Ejiao, to make amends after the sheep is gone Post date April 29, 2022 — 19:23 Post Lock Read More Dong'e Ejiao "repairs after the sheep" Post date April 29, 2022 — 19:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Caishen.CoCaishen.Co